Cargando…
The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis
BACKGROUND: Submucous fibrosis with a high incidence rate in the Indian subcontinent is a devastating disease affecting the oral cavity and oropharynx. AIMS AND OBJECTIVE: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing...
Autores principales: | Kisave, Parag, Shekhar, Vijay, Babu, Prasoon S., Hussaini, Syed W. U., Bhanot, Rishabh, Kumar, Abhinav, Tiwari, Rahul V. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380742/ https://www.ncbi.nlm.nih.gov/pubmed/32754522 http://dx.doi.org/10.4103/jfmpc.jfmpc_268_20 |
Ejemplares similares
-
Evaluation of Hearing Performance in Patients with Oral Submucous Fibrosis in Relation to Different Grades
por: Srivastava, Rahul, et al.
Publicado: (2023) -
Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients
por: Kondaveeti, Satish Srinivas, et al.
Publicado: (2018) -
Aggrandizing oral submucous fibrosis grading using an adjunct special stain: A pilot study
por: Reshma, V, et al.
Publicado: (2016) -
Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015) -
Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)